TargED Biopharmaceuticals
Phase 1TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED’s name stands for Targeted Enzyme Delivery and the company’s unique biological drugs use small antibodies (‘VHH’) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Private Company
Total funding raised: $28.5M
About
TargED Biopharmaceuticals B.V. is a Netherlands based biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis. TargED’s name stands for Targeted Enzyme Delivery and the company’s unique biological drugs use small antibodies (‘VHH’) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.